<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04078100</url>
  </required_header>
  <id_info>
    <org_study_id>Transseptal apprroach</org_study_id>
    <nct_id>NCT04078100</nct_id>
  </id_info>
  <brief_title>Transseptal Approach Versus Conventional Left Atrial Approach for Mitral Valve Procedures</brief_title>
  <official_title>Transseptal Approach Versus Conventional Left Atrial Approach for Mitral Valve Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study Objectives/Specific Aims Overall Goal: To compare between transseptal approach and the
      conventional left atrial approach for mitral valve procedures.

        -  Objective 1: Assess the intraoperative approach related criteria in valve exposure,
           cardiopulmonary bypass time and intraoperative complications.

        -  Objective 2: Assess the outcomes and postoperative results.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mitral valve diseases are considered among the most prevalent valvular heart diseases that
      necessitate surgical intervention.

      as the Modern international guidelines substantially recommend mitral valve repair whenever
      possible there is significant decrease in mitral valve replacement rates.

      Cardiothoracic surgeons have to face the problem of Making a decision regarding mitral valve
      repair, reconstruction or replacement which requires excellent valve exposure for precise
      anatomical definition and manipulation taking in mind cases with specific anatomical
      challenges.

      Since the beginning of modern cardiac surgery only two basic approaches to the mitral valve
      have been described by Effler who wrote in 1958 &quot; the actual entry into the left atrium may
      be accomplished in either of two ways : through the Fossa Ovalis by way of the right atrium
      or through the posterior interatrial groove &quot; Nowadays median sternotomy is still the most
      commonly used incision for mitral valve surgery which allows the best exposure for the valve
      through transseptal incision or through Sandergaard's groove.

      Although the latter approach is the preferred method for most surgeons the transseptal
      approach has been revisited in more recent years in various forms by those seeking better
      exposure of mitral valve especially in cases with difficult anatomy.

      In this paper we try to compare the transseptal approach with the conventional left atrial
      approach for mitral valve procedures to review previous literatures' results and to clarify
      the effect of using each of the two approaches in preoperative ,intra and postoperative
      course .
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2019</start_date>
  <completion_date type="Anticipated">October 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ischemic time</measure>
    <time_frame>intraoperative registration.</time_frame>
    <description>period of time from applying the aortic cross clamp till its removal in open heart surgeries during which there is no blood flow in the coronary arteries and the heart is ischemic.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>whole operation time.</measure>
    <time_frame>intraoperative registration.</time_frame>
    <description>period of time from skin incision to skin closure in open heart surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>re-operation</measure>
    <time_frame>with in the first 24 hrs post operative.</time_frame>
    <description>re exploration through the same incision site to stop bleeding.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative arrhythmias.</measure>
    <time_frame>within the first week post operative.</time_frame>
    <description>newly arising tachy or bradyarrhythmia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay.</measure>
    <time_frame>up to three months</time_frame>
    <description>time of hospital admission postoperative.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Mitral Valve Surgical Approaches</condition>
  <arm_group>
    <arm_group_label>group A</arm_group_label>
    <description>underwent mitral valve surgery through transseptal approach.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group B</arm_group_label>
    <description>underwent mitral valve surgery through conventional left atrial approach.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transseptal approach.</intervention_name>
    <description>surgical approach to the mitral valve through the Fossa Ovalis by way of the right atrium.</description>
    <arm_group_label>group A</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all patients who presented to Cardiothoracic Surgery Department, Assiut University Hospital
        and who meet the listed inclusion from 2016 to 2019 within the range of 100 eligible case.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients underwent mitral valve replacement, mitral valve repair, redo mitral valve
             replacement, combined mitral and tricuspid procedures, combined mitral surgery and
             coronary arteries bypass graft at cardiothoracic surgery department Assiut University
             Hospital.

        Exclusion Criteria:

          -  Patients with congenital mitral valve diseases .

          -  patient refused to sign the informed consent to be a part in the research .
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud Thabet, dr.</last_name>
    <role>Study Director</role>
    <affiliation>general surgery department, AssiutU</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Mahmoud, dr.</last_name>
    <role>Study Director</role>
    <affiliation>cardiothoracic department, AssiutU</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Beshoy Allam, master</last_name>
    <phone>+201009471147</phone>
    <email>beshoui011145@med.au.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed ELminshawy, prof. dr.</last_name>
    <phone>01148185466</phone>
    <email>aelminshawy@aun.edu.eg</email>
  </overall_contact_backup>
  <link>
    <url>https://www.sciencedirect.com/science/article/pii/S1522294215000203</url>
    <description>Malik M, Kilic A. Biatrial Transseptal Approach for Combined Mitral Valve and Tricuspid Valve Operations. Operative Techniques in Thoracic and Cardiovascular Surgery. 2015 ; 20 ( 1 ): 2-16.</description>
  </link>
  <link>
    <url>https://jamanetwork.com/journals/jamasurgery/article-abstract/563256</url>
    <description>Bowman FOJ, Malm JR. The Transseptal Approach to Mitral Valve Repair. JAMA Surgery. 1965 ; 90 ( 3 ): 329-331.</description>
  </link>
  <reference>
    <citation>Rezahosseini O, Rezaei M, Ahmadi Tafti SH, Jalali A, Bina P, Ghiasi A, Karimi A, Abbasi K, Shirzad M, Davoodi S, Salehi Omran A. Transseptal Approach versus Left Atrial Approach to Mitral Valve: A Propensity Score Matching Study. J Tehran Heart Cent. 2015 Oct 27;10(4):188-93.</citation>
    <PMID>26985207</PMID>
  </reference>
  <reference>
    <citation>van der Merwe J, Casselman F. Mitral Valve Replacement-Current and Future Perspectives. Open J Cardiovasc Surg. 2017 Jul 13;9:1179065217719023. doi: 10.1177/1179065217719023. eCollection 2017. Review.</citation>
    <PMID>28757798</PMID>
  </reference>
  <reference>
    <citation>Doty JR, Caine WT. Mitral valve replacement and tricuspid valve repair through a transseptal approach for double-valve endocarditis. Multimed Man Cardiothorac Surg. 2012 Jan 1;2012:mms003. doi: 10.1093/mmcts/mms003.</citation>
    <PMID>24414707</PMID>
  </reference>
  <reference>
    <citation>Nienaber JJ, Glower DD. Minitransseptal versus left atrial approach to the mitral valve: a comparison of outcomes. Ann Thorac Surg. 2006 Sep;82(3):834-9; discussion 839.</citation>
    <PMID>16928494</PMID>
  </reference>
  <reference>
    <citation>Santibáñez Escobar F, Serrano Gallardo G, Ramirez Marroquin S, Lopez Soriano F, Barragán García R. The transseptal approach for mitral valve replacement revisited. Tex Heart Inst J. 1997;24(3):209-14.</citation>
    <PMID>9339510</PMID>
  </reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 2, 2019</study_first_submitted>
  <study_first_submitted_qc>September 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 4, 2019</study_first_posted>
  <last_update_submitted>September 3, 2019</last_update_submitted>
  <last_update_submitted_qc>September 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Beshoy Allam Moris</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>mitral valve replacement</keyword>
  <keyword>transseptal approach</keyword>
  <keyword>left atrial approach</keyword>
  <keyword>mital valve repair</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

